SCHEMBL14136980

SCHEMBL14136980

CCC(=O)N(CC1CCN(C(=O)OCc2ccccc2)CC1)c1cc(-c2ccccc2)sc1C(=O)OC

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.44
▸ NPC1 O15118 2/20 0.44
▸ RAB9A P51151 2/20 0.44
▸ GRIN2B Q13224 11/20 0.44
▸ CYP2D6 P10635 4/20 0.44
▸ CYP2C9 P11712 4/20 0.44
▸ HTT P42858 2/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ ATM Q13315 1/20 0.42
▸ CYP2C19 P33261 1/20 0.41
▸ CYP3A4 P08684 3/20 0.40
▸ MMP1 P03956 1/20 0.40
▸ MMP2 P08253 1/20 0.40
▸ MMP3 P08254 1/20 0.40
▸ MMP7 P09237 1/20 0.40
▸ MMP9 P14780 1/20 0.40
▸ MMP8 P22894 1/20 0.40
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14048985 0.92 SMN1; SMN2 (0.44) SMN1; SMN2NPC1RAB9AGRIN2BCYP2D6
SCHEMBL2879579 0.89 SMN1; SMN2 (0.44) SMN1; SMN2NPC1RAB9AGRIN2BCYP2D6
SCHEMBL14136979 0.86 KDM4E (0.48) SMN1; SMN2NPC1RAB9AHTTKDM4E
SCHEMBL2158340 0.85 SMN1; SMN2 (0.40) SMN1; SMN2NPC1RAB9AGRIN2BCYP2D6
SCHEMBL14030873 0.82 SMN1; SMN2 (0.43) SMN1; SMN2NPC1RAB9AGRIN2BCYP2D6
SCHEMBL6426855 0.81 SMN1; SMN2 (0.45) SMN1; SMN2NPC1RAB9AGRIN2BCYP2D6
SCHEMBL2870816 0.80 HTT (0.40) SMN1; SMN2NPC1RAB9AHTTKDM4E
SCHEMBL12464666 0.80 SMN1; SMN2 (0.45) SMN1; SMN2NPC1RAB9AGRIN2BCYP2D6
SCHEMBL2157890 0.79 GRIN2B (0.57) SMN1; SMN2NPC1RAB9AGRIN2BCYP2D6
SCHEMBL2746312 0.79 SMN1; SMN2 (0.45) SMN1; SMN2NPC1RAB9AGRIN2BCYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7402608-B2 Compounds and methods for the treatment or prevention of Flavivirus infections VIROCHEM PHARMA INC. (CA) 2008-07-22 — — US disclosed
Send feedback